Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that causes the progressive degeneration of motor neurons, the cells responsible for transmitting signals from the brain to the muscles. While the exact cause of this rare disease remains unknown, around 40 genes have been associated with ALS. In a study published in the Journal of Neurology, Neurosurgery, and Psychiatry, we identified a mutation in the ARPP21 gene in ten ALS patients from seven families in a small region of La Rioja, Spain.
What was done in this study?
We noticed an unusually high number of ALS cases, both sporadic and familial, in a small region of La Rioja. To uncover possible genetic causes, we conducted a genomic study. First, we ruled out previously known ALS-related genetic variants. Next, we performed whole-genome sequencing to look for mutations in genes not previously linked to the disease. This analysis revealed a mutation in ARPP21 in four ALS patients. The study was then expanded to include affected family members and additional cases from nearby areas, ultimately identifying ten individuals carrying the mutation.
Key Findings
- A mutation in the ARPP21 gene (c.1586C>T; p.Pro529Leu) was found in ten ALS patients.
- Patients with this mutation experienced rapid disease progression, with a median survival of 16 months.
- Some affected families also had early-onset dementia, suggesting a possible connection between this mutation and other neurodegenerative diseases.
Why is this important?
Our study identifies ARPP21 as a new ALS-associated gene, improving our understanding of the disease’s genetic basis. Discovering new mutations helps refine genetic diagnosis, particularly for inherited cases, and paves the way for developing targeted therapies. Based on these findings, researchers propose adding ARPP21 to genetic diagnostic panels for ALS.